Scorecard: Sirolimus (S-1)
Resected pancreatic cancer
- Tumour Type
- Gastrointestinal Cancers
- Tumour Subtype
- Pancreatic cancer
- Trial Name
- JASPAC 01
News
FDA Approves Cabozantinib for Adults and Paediatric Patients 12 Years of Age and Older with pNET and epNET
Evidence for efficacy is based on the results from the CABINET study
News
Efficacy of Taletrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC
Findings from an integrated analysis of the pivotal phase II regional TRUST-I and global TRUST-II studies
Policy
ESMO Calls for Putting Cancer at the Centre of the EU’s Strategy for European Life Sciences
Robust life sciences are fundamental for advancing the understanding of cancer, driving therapeutic innovation in oncology, and ultimately delivering new treatments benefitting patients with cancer.
News
EMA Recommends Extension of Indications for Glofitamab
New indication concerns the treatment of adult patients with relapsed or refractory DLBCL not otherwise specified who are ineligible for autologous stem cell transplant
News
Cancer Mortality Prediction for 2025 Continues to Show Favourable Trends In the EU
An up-to-date projection of cancer mortality patterns in the European Union